The toxicology and characteristics of fatal new psychoactive stimulant and hallucinogen-related poisonings in Australia, 2000–2025
Authors:
Open Access
- 22 March 2026
- journal article
- Published by Elsevier in Drug and Alcohol Dependence Reports
- Vol. 19, 100434
Abstract
No abstract availableKeywords
Funding Information
- National Drug and Alcohol Research Centre
- National Health and Medical Research Council (1174630)
This publication has 17 references indexed in Scilit:
- Novel psychoactive substances in Australian emergency departments: implications for public health practice from multi-centre prospective toxicosurveillance across five states, 2022–2023International Journal of Drug Policy, 2025
- Fatalities following DMT use: two case reports and a review of the literatureJournal of Analytical Toxicology, 2025
- Cardiotoxicity After Synthetic Cathinone Use; Two Cases, A Case Series and Scoping ReviewCardiovascular Toxicology, 2024
- Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMeJournal of Analytical Toxicology, 2022
- Neurotoxicological profile of the hallucinogenic compound 25I-NBOMeScientific Reports, 2022
- Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in AustraliaDrug and Alcohol Dependence, 2019
- Dopaminergic neurotoxic effects of 3-TFMPP derivativesLife Sciences, 2018
- A literature review of blood concentrations of new psychoactive substances classified as phenethylamines, aminoindanes, arylalkylamines, arylcyclohexylamines, and indolalkylaminesForensic Science International, 2017
- Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A ReviewJournal of Analytical Toxicology, 2017
- A Case of Fatal Benzylpiperazine (BZP) and Trifluoromethylphenylpiperazine (TFMPP) ToxicityCanadian Society of Forensic Science Journal, 2012